Trial Profile
Second study of TRPV1 and TRPA1 receptor targeted therapy in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs FLX 787 (Primary)
- Indications Neuromuscular disorders
- Focus Adverse reactions
- 07 Aug 2015 New trial record